198 related articles for article (PubMed ID: 21549795)
1. Extended safety and efficacy studies of a live attenuated double leucine and pantothenate auxotroph of Mycobacterium tuberculosis as a vaccine candidate.
Sampson SL; Mansfield KG; Carville A; Magee DM; Quitugua T; Howerth EW; Bloom BR; Hondalus MK
Vaccine; 2011 Jun; 29(29-30):4839-47. PubMed ID: 21549795
[TBL] [Abstract][Full Text] [Related]
2. Protection elicited by a double leucine and pantothenate auxotroph of Mycobacterium tuberculosis in guinea pigs.
Sampson SL; Dascher CC; Sambandamurthy VK; Russell RG; Jacobs WR; Bloom BR; Hondalus MK
Infect Immun; 2004 May; 72(5):3031-7. PubMed ID: 15102816
[TBL] [Abstract][Full Text] [Related]
3. A recombinant attenuated Mycobacterium tuberculosis vaccine strain is safe in immunosuppressed simian immunodeficiency virus-infected infant macaques.
Jensen K; Ranganathan UD; Van Rompay KK; Canfield DR; Khan I; Ravindran R; Luciw PA; Jacobs WR; Fennelly G; Larsen MH; Abel K
Clin Vaccine Immunol; 2012 Aug; 19(8):1170-81. PubMed ID: 22695156
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of live attenuated persistent and rapidly cleared Mycobacterium tuberculosis vaccine candidates in non-human primates.
Larsen MH; Biermann K; Chen B; Hsu T; Sambandamurthy VK; Lackner AA; Aye PP; Didier P; Huang D; Shao L; Wei H; Letvin NL; Frothingham R; Haynes BF; Chen ZW; Jacobs WR
Vaccine; 2009 Jul; 27(34):4709-17. PubMed ID: 19500524
[TBL] [Abstract][Full Text] [Related]
5. Mycobacterium tuberculosis DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis.
Sambandamurthy VK; Derrick SC; Hsu T; Chen B; Larsen MH; Jalapathy KV; Chen M; Kim J; Porcelli SA; Chan J; Morris SL; Jacobs WR
Vaccine; 2006 Sep; 24(37-39):6309-20. PubMed ID: 16860907
[TBL] [Abstract][Full Text] [Related]
6. Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials.
Arbues A; Aguilo JI; Gonzalo-Asensio J; Marinova D; Uranga S; Puentes E; Fernandez C; Parra A; Cardona PJ; Vilaplana C; Ausina V; Williams A; Clark S; Malaga W; Guilhot C; Gicquel B; Martin C
Vaccine; 2013 Oct; 31(42):4867-73. PubMed ID: 23965219
[TBL] [Abstract][Full Text] [Related]
7. Balancing Trained Immunity with Persistent Immune Activation and the Risk of Simian Immunodeficiency Virus Infection in Infant Macaques Vaccinated with Attenuated Mycobacterium tuberculosis or Mycobacterium bovis BCG Vaccine.
Jensen K; Dela Pena-Ponce MG; Piatak M; Shoemaker R; Oswald K; Jacobs WR; Fennelly G; Lucero C; Mollan KR; Hudgens MG; Amedee A; Kozlowski PA; Estes JD; Lifson JD; Van Rompay KK; Larsen M; De Paris K
Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27655885
[TBL] [Abstract][Full Text] [Related]
8. A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis.
Sambandamurthy VK; Wang X; Chen B; Russell RG; Derrick S; Collins FM; Morris SL; Jacobs WR
Nat Med; 2002 Oct; 8(10):1171-4. PubMed ID: 12219086
[TBL] [Abstract][Full Text] [Related]
9. Sterilization by Adaptive Immunity of a Conditionally Persistent Mutant of Mycobacterium tuberculosis.
Vilchèze C; Porcelli SA; Chan J; Jacobs WR
mBio; 2021 Jan; 12(1):. PubMed ID: 33468684
[No Abstract] [Full Text] [Related]
10. Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis.
Hondalus MK; Bardarov S; Russell R; Chan J; Jacobs WR; Bloom BR
Infect Immun; 2000 May; 68(5):2888-98. PubMed ID: 10768986
[TBL] [Abstract][Full Text] [Related]
11. MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques.
Verreck FA; Vervenne RA; Kondova I; van Kralingen KW; Remarque EJ; Braskamp G; van der Werff NM; Kersbergen A; Ottenhoff TH; Heidt PJ; Gilbert SC; Gicquel B; Hill AV; Martin C; McShane H; Thomas AW
PLoS One; 2009; 4(4):e5264. PubMed ID: 19367339
[TBL] [Abstract][Full Text] [Related]
12. Mycobacterium tuberculosis sigE mutant ST28 used as a vaccine induces protective immunity in the guinea pig model.
Troudt J; Creissen E; Izzo L; Bielefeldt-Ohmann H; Casonato S; Manganelli R; Izzo AA
Tuberculosis (Edinb); 2017 Sep; 106():99-105. PubMed ID: 28802412
[TBL] [Abstract][Full Text] [Related]
13.
Jia Q; Masleša-Galić S; Nava S; Horwitz MA
mBio; 2022 Jun; 13(3):e0068722. PubMed ID: 35642945
[TBL] [Abstract][Full Text] [Related]
14. CD8 T Cells Show Protection against Highly Pathogenic Simian Immunodeficiency Virus (SIV) after Vaccination with SIV Gene-Expressing BCG Prime and Vaccinia Virus/Sendai Virus Vector Boosts.
Kato S; Shida H; Okamura T; Zhang X; Miura T; Mukai T; Inoue M; Shu T; Naruse TK; Kimura A; Yasutomi Y; Matsuo K
J Virol; 2021 Jan; 95(4):. PubMed ID: 33087465
[TBL] [Abstract][Full Text] [Related]
15. Long-term protection against tuberculosis following vaccination with a severely attenuated double lysine and pantothenate auxotroph of Mycobacterium tuberculosis.
Sambandamurthy VK; Derrick SC; Jalapathy KV; Chen B; Russell RG; Morris SL; Jacobs WR
Infect Immun; 2005 Feb; 73(2):1196-203. PubMed ID: 15664964
[TBL] [Abstract][Full Text] [Related]
16. Construction and Characterization of the Mycobacterium tuberculosis
Hernandez-Pando R; Shin SJ; Clark S; Casonato S; Becerril-Zambrano M; Kim H; Boldrin F; Mata-Espinoza D; Provvedi R; Arbues A; Marquina-Castillo B; Cioetto Mazzabò L; Barrios-Payan J; Martin C; Cho SN; Williams A; Manganelli R
Infect Immun; 2019 Dec; 88(1):. PubMed ID: 31591165
[TBL] [Abstract][Full Text] [Related]
17. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
18. Revaccination of Guinea Pigs With the Live Attenuated Mycobacterium tuberculosis Vaccine MTBVAC Improves BCG's Protection Against Tuberculosis.
Clark S; Lanni F; Marinova D; Rayner E; Martin C; Williams A
J Infect Dis; 2017 Sep; 216(5):525-533. PubMed ID: 28329234
[TBL] [Abstract][Full Text] [Related]
19. Establishment of an aerosol challenge model of tuberculosis in rhesus macaques and an evaluation of endpoints for vaccine testing.
Sharpe SA; McShane H; Dennis MJ; Basaraba RJ; Gleeson F; Hall G; McIntyre A; Gooch K; Clark S; Beveridge NE; Nuth E; White A; Marriott A; Dowall S; Hill AV; Williams A; Marsh PD
Clin Vaccine Immunol; 2010 Aug; 17(8):1170-82. PubMed ID: 20534795
[TBL] [Abstract][Full Text] [Related]
20. Development of therapeutic and prophylactic vaccine against Tuberculosis using monkey and transgenic mice models.
Kita Y; Okada M; Nakajima T; Kanamaru N; Hashimoto S; Nagasawa T; Kaneda Y; Yoshida S; Nishida Y; Nakatani H; Takao K; Kishigami C; Nishimatsu S; Sekine Y; Takamori Y; McMurray DN; De la Cruz EC; Tan EV; Abalos RM; Burgos JA; Saunderson P; Sakatani M
Hum Vaccin; 2011; 7 Suppl():108-14. PubMed ID: 21263229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
